/cdn.vox-cdn.com/uploads/chorus_image/image/42842242/20140706_jla_cs1_606.jpg.0.jpg)
After finally making his much-anticipated Octagon debut at The Ultimate Fighter (TUF) 19 Finale back in July with an impressive submission victory over Keith Berish, Robert Drysdale's win, unfortunately, was overturned to a No Contest (NC) after a post-fight drug test revealed elevated levels of testosterone.
Soon thereafter, the Nevada State Athletic Commission (NSAC) temporarily suspended the jiu-jitsu wizard for the infraction. According to MMA Fighting, the NSAC has now hit Drysdale with a one-year suspension.
The report stated that Drysdale admitted he was on testosterone replacement therapy (TRT), but put a halt to it two months before making his UFC debut. Of course, he failed to mention any of that to the doctors on hand during his pre-fight medicals.
That's an interesting tidbit, as the state of Nevada banned TRT in February of this year, which means by Drysdale's timeline, he was still on the controversial treatment for a month or so after.
But, the writing was on the wall, as he was previously denied a license to compete in Nevada due to high levels of testosterone back in October, putting his Octagon debut on hold. As far as his UFC future, well it's non-existent, as the promotion parted ways with the submission ace on the heels of his failed drug tests.
Nevertheless, Drysdale will need to get his testosterone levels in check within the following year if he wants to compete in MMA in the state of Nevada for another promotion.